Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Guangzhou Innogen Pharmaceutical Group Co Ltd Class H ( (HK:2591) ) just unveiled an update.
Guangzhou Innogen Pharmaceutical Group Co., Ltd. announced the inclusion of its H shares in the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect programs, effective from December 8, 2025. This strategic move is expected to broaden the company’s investor base and improve trading liquidity, thereby enhancing the investment value of its H shares and strengthening its position in the capital market.
More about Guangzhou Innogen Pharmaceutical Group Co Ltd Class H
Guangzhou Innogen Pharmaceutical Group Co., Ltd. is a joint stock company based in the People’s Republic of China, operating within the pharmaceutical industry. The company focuses on developing and providing pharmaceutical products and services, aiming to enhance its market presence and reputation.
Average Trading Volume: 494,827
Find detailed analytics on 2591 stock on TipRanks’ Stock Analysis page.